Supplementary Appendix

Similar documents
Understanding Blood Tests

Eastern Maine Medical Center Patient Price Information Effective October 1, 2017 September 30, 2018

Rapid Laboratories In House Tests

2017 Patient Pricelist

M.D.IPA, M.D.IPA Preferred, Optimum Choice and Optimum Choice Preferred STAT Laboratory List Revised Jan. 5, 2017

DEPARTMENT: Regulatory Compliance Support

Inspector's Accreditation Unit Activity Menu

Chemistry Reference Ranges and Critical Values

Chemistry Reference Ranges and Critical Values

10 Essential Blood Tests PART 1

Supplementary materials

Subject ID: I N D # # U A * Consent Date: Day Month Year

ROUTINE LAB STUDIES. Routine Clinic Lab Studies

PRE SURGICAL TESTING DEPARTMENT ADVOCATE LUTHERAN GENERAL HOSPITAL STANDARD FOR CHART REVIEW

SMALL ANIMAL SOFT TISSUE CASE-BASED EXAMINATION

Delta Check Calculation Guide

2014 Notice to Physicians

BASIC METABOLIC PANEL

What is PlaqueOff (PO)? A new study in Beagle dogs. Oral effects of

Comparison of Risk Factors for Unplanned Conversion from Laparoscopic and Robotic to Open Colorectal Surgery

Online catalog

To be used for the ease of test requisitioning on select patients only; all components may be ordered separately

SMALL ANIMAL SOFT TISSUE CASE- BASED EXAMINATION

Epic Labs Orderable As STAT PRIORITY As of 06/22/2016

Supplementary Appendix

Tables of Normal Values (As of February 2005)

Variable Included. Excluded. Included. Excluded

i. Where is the participant seen?

Multiphasic Blood Analysis

Supplementary Online Content

2015 Annual Notice to Providers

Preoperative Medical Testing in Medicare Patients Undergoing Cataract Surgery

Specimen Collection Requirements

Routine Clinic Lab Studies

Specimen Collection Requirements

H.6.G.2 Non-MAC Studies

Annual Notice to Providers (2014)

Individual Study Table Referring to Part of the Dossier. Use only) Name of Finished Product:

The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care

Community health day. General Robert H. Reed Recreation Center 800 Gabreski Lane, Myrtle Beach Friday, May 11 7:30-10:30 a.m.

Results Report. Welcome to Your ABT Report!

COMPANY OR UNIVERSITY

Patient Encounter Skills. Lesson 7: Case Presentation. MED 2016 Clinical English Course. Takayuki OSHIMI MD. MED 2016 Clinical English Course

Benefits and Harms of Routine Preoperative Testing: A Comparative Effectiveness Review

Basic Metabolic Panel

Efficacy and safety of brexpiprazole for the treatment of acute. schizophrenia: a 6-week, randomized, double-blind, placebocontrolled

1.) 3 yr old FS Siamese cat: 3 day history of lethargy, anorexia. Dyspneic, thin, febrile.

During the past two decades,

Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS

Cycle 1 PERTuzumab (day 1) and trastuzumab (day 2) loading doses: Drug Dose BC Cancer Administration Guideline

Comparison of VACUETTE Heparin Gel Tubes for Common Chemistry Analytes

PENN STATE MILTON S. HERSHEY MEDICAL CENTER TABLE OF CRITICAL LAB VALUES CURRENT AS OF: 1/2015

SUPPLEMENTAL MATERIAL

What Does My Blood Test Mean

ENROLLMENT CONFIRMATION

NORMAL LABORATORY VALUES FOR CHILDREN

Serodos and Serodos plus

Refugee Health Funding Models: A Review of PA Models and A Vision for the Future

What is the routine? What do they tell us?

BIOCHEMICAL REPORT. Parameters Unit Finding Normal Value. Lipase U/L Amylase U/L

Sutter Health Plus Effective for Calendar Year 2015

JOB AID CRITICAL VALUES AND TESTS W/O MICRO CRITICAL TESTS. Always call results for the following test(s):

BC Cancer Protocol Summary for Therapy of Acute Myeloid Leukemia Using azacitidine and SORAfenib

Fullerton Healthcare Screening Centres

Get to know yourself better. Attend our health screening event.

Cycle 1-6 (28 Days) Days 15&16 1&2 8. (±2 Days) (±2 Days) (±7 Days) (+7 days) X X X X X X X

Sage Program Reimbursement Rates (Effective Jan 1, 2018 through Dec 31, 2018)

PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert.

Supplementary Appendix

Clinician Blood Panel Results

HOVON 141 CLL. Version 3, 25JUL2018. Table Required investigations at entry, during treatment and during follow up.

The Blood Chemistry Panel Explained

Chapter 1. Perioperative Evaluation and Management of Surgical Patients. Oral Exam Questions

How to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion

Unclear ALT Yes Monthly for first 3 months, then every 3 months EFV: 6 weeks. count, chemistry Full blood count, Creatinine, ALT, AST

PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert.

CLIA APPROVED PROFICIENCY TESTING PROGRAMS ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts (800)

2011 FITWAY Allowable CPT Codes (Modifiers are to be reported with appropriate CPT codes at the discretion of the Provider or Facility)

Alaska Native Medical Center Anchorage, AK

Baseline Data Collection Tool

The positive side of overdiagnosis

patient characteriuics Chapter Two introduction 58 increasing complexity of the patient population 60 epo use & anemia in the pre-esrd period 62

Total Cost of Ownership (TCO): An evidence-based approach to compare laboratory equipment

Synopsis. Adalimumab M Clinical Study Report R&D/09/060. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:

Pediatric emergencies (SHOCK & COMA) Dr Mubarak Abdelrahman Assistant Professor Jazan University

BC Cancer Protocol Summary for Therapy of Adjuvant Breast Cancer using Capecitabine

ELIGIBILITY: Newly diagnosed acute promyelocytic leukemia (APL) with high risk (WBC more than 10 x 10 9 /L)

Module 7 Your Blood Work

Get to know yourself better. Attend our health screening event.

2012 FITWAY Allowable CPT Codes (Modifiers are to be reported with appropriate CPT codes at the discretion of the Provider or Facility)

Itemized Billing and Procedure Description for the AspireAssist

Add your company slogan LOGO

Documentation Dissection

Supplementary Appendix

Results Report. Welcome to Your ABT Report! Introduction to the ABT Report

Hamilton Regional Laboratory Medicine Program

GENERAL INFORMATION CLINICAL LABORATORY PHONE DIRECTORY

Supplementary Online Content

Lab Values Chart. Name of Test Purpose Normal Range (Adult) High Results Mean Low Results Mean. 1 5 or 1.5 (depends on unit of measure)

COG-ACNS1123: Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT)

Transcription:

Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Chen CL, Lin GA, Bardach NS, et al. Preoperative medical testing in Medicare patients undergoing cataract surgery. N Engl J Med 2015;372:1530-8. DOI: 10.1056/NEJMsa1410846

Preoperative Medical Testing Prior to Cataract Surgery in Medicare Patients SUPPLEMENTARY MATERIALS

TABLE OF CONTENTS 1. Figure S1a: Receiver operating curves depicting differential contributions of patient characteristics, ophthalmologist and preoperative office visit to the likelihood of preoperative testing 2. Figure S1b. Receiver operating curves depicting differential contributions of patient characteristics, ophthalmologist and preoperative office visit to the likelihood of preoperative testing (shown without Ophthalmologist + All Other Variables (without Office Visit) model) 3. Table S1: CPT codes used for specified preoperative tests 4. Table S2: Characteristics of cataract surgery patients who did and did not undergo preoperative testing in the 30 days before index cataract surgery (includes all health system variables) 5. Table S3: Characteristics of cataract surgery patients who did and did not have a preoperative office visit in the 30 days before index cataract surgery 6. Table S4: Prevalence and cost of medical services provided in the 30 days before index cataract surgery 7. Table S5: Characteristics associated with preoperative testing prior to cataract surgery (models include office visits as a predictor) 8. Table S6: Characteristics associated with having a preoperative office visit prior to cataract surgery

Figure S1a. Receiver operating curves depicting differential contributions of patient characteristics, ophthalmologist and preoperative office visit to the likelihood of preoperative testing 1 1 0.9 0.8 Sensi2vity 0.7 0.6 0.5 0.4 0.3 Pa2ent Baseline Characteris2cs Only Ophthalmologist Only Ophthalmologist + All Other Variables (without Office Visit) Ophthalmologist + Office Visit 0.2 0.1 Ophthalmologist + All Other Variables (with Office Visit) 0 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1- Specificity 1) C-statistics for each model: patient baseline characteristics: 0.60; ophthalmologist only: 0.78; ophthalmologist plus all other variables except office visit: 0.80; ophthalmologist plus office visit: 0.84; ophthalmologist plus all other variables including office visit: 0.85 3

Figure S1b. Receiver operating curves depicting differential contributions of patient characteristics, ophthalmologist and preoperative office visit to the likelihood of preoperative testing 1,2 1 0.9 0.8 Sensi2vity 0.7 0.6 0.5 0.4 0.3 0.2 Pa2ent Baseline Characteris2cs Only Ophthalmologist Only Ophthalmologist + Office Visit Ophthalmologist + Office Visit + All Other Variables 0.1 0 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1- Specificity 1) C-statistics for each model: patient baseline characteristics: 0.60; ophthalmologist only: 0.78; ophthalmologist plus office visit: 0.84; ophthalmologist plus office visit plus all other variables: 0.85 2) Figure S1b does not depict the model Ophthalmologist + All Other Variables (without Office Visit) shown in Figure S1a. 4

Table S1: CPT codes used for specified preoperative tests Test grouping Preoperative Test Name CPT Code Basic metabolic panel (Na, K, Cl, CO2, BUN, Chemistry panel Cr, Glucose, ica/ca) 80047, 80048 Chemistry panel Electrolyte panel (Na, K, Cl, CO2) 80051 Chemistry panel Comprehensive metabolic panel (Na, K, Cl, CO2, BUN, Cr, Glu, AST, ALT, Alk phos, Tprot, Albumin, Tbili, Ca) 80053 Chemistry panel Renal function panel (Na, K, Cl, CO2, BUN, Cr, Glucose, Ca, PO4, Albumin) 80069 Chemistry panel Hepatic function panel (AST, ALT, Alk phos, TProt, Albumin, TBili, DBili) 80076 Chemistry panel Calcium, serum 82310 Chemistry panel Calcium, ionized 82330 Chemistry panel Bicarbonate 82374 Chemistry panel Chloride 82435 Chemistry panel Glucose 82947 Chemistry panel Magnesium 83735 Chemistry panel Phosphorus 84100 Chemistry panel Potassium 84132 Chemistry panel Sodium 84295 Chemistry panel Creatinine 82565 Chemistry panel BUN 84520 Chemistry panel Albumin 82040 Chemistry panel Bilirubin, total 82247 Chemistry panel Bilirubin, direct 82248 Chemistry panel Alkaline phosphatase 84075 Chemistry panel Total protein 84155 Chemistry panel AST 84450 Chemistry panel ALT 84460 Complete blood count CBC 85025, 85027 Complete blood count Hematocrit 85014 Complete blood count Hemoglobin 85018 Complete blood count WBC 85048 Complete blood count Platelet count 85049 Coagulation panel PT w/inr 85610 Coagulation panel PTT 85730 81000, 81001, 81002, Urinalysis Urinalysis 81003, 81005 Electrocardiography 12-lead EKG 93000, 93005, 93010 Echocardiography TTE 93306, 93307 Cardiac stress test Stress EKG 93015, 93016, 93017, 93018 Cardiac stress test Stress echo 93350, 93351, +/- 93352 Cardiac stress test Stress MRI 75561, 75563 Cardiac stress test Myocardial Perfusion Imaging, SPECT 78451, 78452 Cardiac stress test Myocardial Perfusion Imaging, planar 78453, 78454 Chest radiograph CXR 71010, 71020 Pulmonary function tests Spirometry 94010 Bronchodilation responsiveness, spirometry Pulmonary function tests pre- and post-bronchodilator administration 94060 Pulmonary function tests Plethysmography 93720, 93721, 93722 Functional residual capacity or residual Pulmonary function tests volume: helium, nitrogen 94240 Pulmonary function tests Thoracic gas volume 94260 Determination of maldistribution of inspired Pulmonary function tests gas: helium, nitrogen 94350 Pulmonary function tests Airway closing volume 94370 Pulmonary function tests Resistance to airflow 94360 Pulmonary function tests CO diffusing capacity 94720 Pulmonary function tests Membrane diffusion capacity 94725 5

Table S2. Characteristics of cataract surgery patients who did and did not undergo preoperative testing in the 30 days before index cataract surgery (includes all health system variables) 1,2 Patient Characteristics Preoperative testing (N= 232,889) 6 No preoperative testing (N= 207,968) Age, mean in years (SD) 76.5 (6.3) 75.7 (6.2) Sex Male 40 40 Female 60 60 Race White 87 90 Black 7 6 Other 6 5 Charlson Comorbidity Index 0-1 54 69 2 17 14 3+ 29 17 Health System Characteristics US region Northeast 23 10 Midwest 23 25 South 37 46 Mountain West 4 8 Pacific West 13 10 Population density Urban 84 81 Rural 16 19 Primary care physicians per 100,000 residents 3 Q1 (43.9-63.3) 22 29 Q2 (63.5-69.0) 23 28 Q3 (69.1-77.9) 26 24 Q4 (78.4-117) 30 19 Ophthalmologists per 100,000 residents 3 Q1 (1.6-4.2) 24 30 Q2 (4.3-4.7) 22 29 Q3 (4.8-5.6) 24 24 Q4 (5.7-10.6) 31 17 Ophthalmologist annual cataract surgery volume 4 Q1 (1-39) 29 20 Q2 (40-68) 26 24 Q3 (69-120) 24 27 Q4 (121-662) 20 30 Medicare expenditures per beneficiary in HRR (2010 USD) Q1 ($6,911-$8,689) 25 25 Q2 ($8,691-$9,674) 24 26 Q3 ($9,693-$10,311) 27 24 Q4 ($10,341-$13,824) 24 25 Surgical Setting Ambulatory surgery center 64 71 Hospital outpatient department 34 28 Unknown 2 1 Preoperative Office Visit Yes 73 28 No 27 72 1) All numbers shown as column percent unless otherwise specified. 2) P-values for all variables were less than 0.001. 3) HRR variables current as of 2006. 4) Ophthalmologist annual cataract surgery volume was calculated for the year 2011 using Medicare billing data.

Table S3. Characteristics of cataract surgery patients who did and did not have a preoperative office visit in the 30 days before index cataract surgery 1,2 Patient Characteristics Preoperative office visit (N=229,832) No preoperative office visit (N=211,025) Age, mean in years (SD) 76.4 (6.3) 75.8 (6.2) Sex Male 40 41 Female 60 59 Race White 88 89 Black 6 6 Other 6 5 Charlson Comorbidity Index 0-1 57 66 2 16 14 3+ 27 20 Health System Characteristics US region Northeast 23 10 Midwest 24 24 South 37 46 Mountain West 4 8 Pacific West 12 11 Population density Urban 86 79 Rural 14 21 Primary care physicians per 100,000 residents 3 Q1 (43.9-63.3) 21 30 Q2 (63.5-69.0) 22 28 Q3 (69.1-77.9) 27 22 Q4 (78.4-117) 29 20 Ophthalmologists per 100,000 residents 3 Q1 (1.6-4.2) 23 31 Q2 (4.3-4.7) 21 29 Q3 (4.8-5.6) 24 23 Q4 (5.7-10.6) 32 17 Ophthalmologist annual cataract surgery volume 4 Q1 (1-39) 28 21 Q2 (40-68) 27 23 Q3 (69-120) 24 27 Q4 (121-662) 21 29 Medicare expenditures per beneficiary in HRR (2010 USD) Q1 ($6,911-$8,689) 25 26 Q2 ($8,691-$9,674) 25 25 Q3 ($9,693-$10,311) 26 24 Q4 ($10,341-$13,824) 24 25 Surgical Setting Ambulatory surgery center 67 68 Hospital outpatient department 32 31 Unknown 1 2 1) All numbers shown as column percent unless otherwise specified. 2) P-values for all variables were less than 0.001. 3) HRR variables current as of 2006. 4) Ophthalmologist annual cataract surgery volume was calculated for the year 2011 using Medicare billing data. 7

Table S4. Prevalence and cost of medical services provided in the 30 days before index cataract surgery Type of medical service Number of beneficiaries receiving medical service 1 (%) Number of medical services performed 1 Annual cost USD Change in number of services over baseline period 2 (%) Change in cost over baseline period 2 USD (%) Chemistry panel 160,518 (36.4) 257,280 2,899,982 91,737 (55.4) 1,068,376 (58.3) Complete blood count 131,776 (29.9) 154,523 1,562,794 68,782 (80.2) 681,006 (77.2) Electrocardiography 123,081 (27.9) 163,519 2,507,544 113,067 (224.1) 1,832,568 (271.5) Urinalysis 49,897 (11.3) 57,073 226,028 17,820 (45.4) 70,715 (45.5) Coagulation panel (PT, PTT) 46,967 (10.7) 85,453 520,598 23,671 (38.3) 162,078 (45.2) Chest radiograph 23,819 (5.4) 40,406 1,218,825-1,190 (-2.9) 43,317 (3.7) Echocardiography 9,034 (2.0) 11,981 2,775,937 498 (4.3) 117,798 (4.4) Cardiac stress test 6,379 (1.4) 17,559 3,964,011 3,486 (24.8) 808,873 (25.6) Pulmonary function tests 4,393 (1.0) 10,356 473,704 496 (5.0) 19,732 (4.3) All preoperative tests 232,889 (52.8) 798,150 16,149,424 318,366 (66.4) 4,804,462 (42.3) Preoperative office visit 229,832 (52.1) 308,397 28,347,459 118,902 (62.7) 12,435,908 (78.2) All medical services combined 292,139 (66.3) 1,106,547 44,496,882 437,269 (65.3) 17,240,370 (63.3) 1) The sum of beneficiaries undergoing each medical service and the number of services performed may exceed the total number of beneficiaries because some patients may have had more than one type of test or office visit during the preoperative period. 2) Total services and costs during the baseline period were calculated by first averaging the totals for each month separately, then calculating the monthly mean for the 11-month baseline period. The baseline mean number of services and costs were then subtracted from the number of services and costs, respectively, that occurred during the preoperative month to calculate the change over baseline.

Table S5. Characteristics associated with preoperative testing prior to cataract surgery (models include office visits as a predictor) Ophthalmologist Baseline patient characteristics only Ophthalmologist only Ophthalmologist plus office visit plus office visit plus all other variables Characteristic AOR (95% CI) AOR (95% CI) AOR (95% CI) AOR (95% CI) Age 1 1.19 (1.18-1.20) - - 1.08 (1.07-1.10) Sex Male Ref - - Ref Female 1.04 (1.03-1.05) - - 0.97 (0.95-0.98) Race White Ref - - Ref Black 1.04 (1.01-1.06) - - 1.03 (0.99-1.06) Other 1.31 (1.28-1.35) - - 0.94 (0.91-0.98) Charlson Comorbidity Index 0-1 Ref - - Ref 2 1.51 (1.49-1.54) - - 1.49 (1.46-1.52) 3+ 2.20 (2.16-2.23) - - 2.18 (2.14-2.22) US region Pacific West - - - Ref Northeast - - - 1.38 (1.27-1.50) Midwest - - - 0.74 (0.69-0.81) South - - - 0.76 (0.71-0.82) Mountain West - - - 0.59 (0.53-0.66) Population density Urban - - - Ref Rural - - - 0.95 (0.90-1.00) Primary care physicians per 100,000 residents 1,2 - - - 1.05 (1.02-1.08) Ophthalmologists per 100,000 residents 2 - - - 1.17 (1.14-1.20) Ophthalmologist annual cataract surgery volume 1 - - - 0.98 (0.97-0.98) Medicare expenditures per beneficiary in HRR (2010 USD) Q1 ($6,911-$8,689) - - - Ref Q2 ($8,691-$9,674) - - - 1.06 (0.99-1.13) Q3 ($9,693-$10,311) - - - 1.06 (0.99-1.13) Q4 ($10,341-$13,824) - - - 1.20 (1.11-1.29) Surgical setting Ambulatory surgery center - - - Ref Hospital outpatient department - - - 1.42 (1.38-1.47) Ophthalmologist 3-3.40 (3.33-3.47) 2.90 (2.84-2.96) 2.63 (2.58-2.68) Had preoperative office visit - - 6.12 (6.02-6.22) 5.94 (5.84-6.03) C-statistic for area under ROC 5 0.60 0.78 0.84 0.85 1) Age, surgery volume, and primary care physicians per 100,000 residents were divided by 10 to allow for more meaningful odds ratios. 2) HRR variables current as of 2006. 3) The influence of the ophthalmologist was summarized by the median odds ratio (MOR), which is the median ratio of the odds of preoperative testing between equivalent patients of two randomly selected ophthalmologists (n=10,507).

Table S6. Characteristics associated with having a preoperative office visit prior to cataract surgery Ophthalmologist Baseline patient characteristics only Ophthalmologist only plus all other variables Characteristic AOR (95% CI) AOR (95% CI) AOR (95% CI) Age 1 1.15 (1.14-1.16) - 1.05 (1.04-1.06) Sex Male Ref - Ref Female 1.10 (1.09-1.11) - 1.08 (1.06-1.09) Race White Ref - Ref Black 0.91 (0.88-0.93) - 0.86 (0.84-0.89) Other 1.29 (1.26-1.33) - 0.97 (0.94-1.01) Charlson Comorbidity Index 0-1 Ref - Ref 2 1.32 (1.29-1.34) - 1.31 (1.29-1.34) 3+ 1.60 (1.57-1.62) - 1.60 (1.57-1.63) US region Pacific West - - Ref Northeast - - 2.04 (1.87-2.23) Midwest - - 1.19 (1.10-1.30) South - - 0.94 (0.86-1.01) Mountain West - - 0.62 (0.55-0.69) Population density Urban - - Ref Rural - - 0.75 (0.72-0.79) Primary care physicians per 100,000 residents 1,2 - - 1.05 (1.02-1.08) Ophthalmologists per 100,000 residents 2 - - 1.17 (1.14-1.20) Ophthalmologist annual cataract surgery volume 1 - - 0.98 (0.97-0.98) Medicare expenditures per beneficiary in HRR (2010 USD) Q1 ($6,911-$8,689) - - Ref Q2 ($8,691-$9,674) - - 1.00 (1.94-1.07) Q3 ($9,693-$10,311) - - 0.91 (0.85-0.98) Q4 ($10,341-$13,824) - - 1.15 (1.07-1.23) Surgical setting Ambulatory surgery center - - Ref Hospital outpatient department - - 0.86 (0.84-0.89) Ophthalmologist 3-3.13 (3.07-3.20) 2.77 (2.72-2.82) C-statistic for area under ROC 0.57 0.79 0.79 1) Age, surgery volume, and primary care physicians per 100,000 residents were divided by 10 to allow for more meaningful odds ratios. 2) HRR variables current as of 2006. 3) The influence of the ophthalmologist was summarized by the median odds ratio (MOR), which is the median ratio of the odds of preoperative testing between equivalent patients of two randomly selected ophthalmologists (n=10,507).